Trillium Therapeutics Stock
Your prediction
Trillium Therapeutics Stock
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Trillium Therapeutics stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Trillium Therapeutics in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Trillium Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Trillium Therapeutics | - | - | - | - | - | - | - |
| Enwave Corporation | 2.330% | -8.594% | -18.750% | -55.000% | -50.424% | -35.359% | -81.190% |
| Aurinia Pharmaceuticals Inc. | -1.010% | 1.255% | -8.333% | 37.216% | -1.188% | 53.165% | 3.660% |
| Spectral Medical Inc | 1.800% | -1.765% | 1.829% | -24.775% | 5.031% | 317.500% | 276.126% |
Comments
News
Is TETRA Technologies a Buy After An Insider Bought 22,000 Shares?
Kurt Hallead, VP-Treasurer & IR at TETRA Technologies (NYSE:TTI), reported an open-market purchase of 22,000 shares for a transaction value of approximately $217,000, according to a SEC Form 4
